login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ABCELLERA BIOLOGICS INC (ABCL) Stock News
USA
- NASDAQ:ABCL -
CA00288U1066
-
Common Stock
3.69
USD
+0.07 (+1.93%)
Last: 11/14/2025, 8:00:00 PM
3.79
USD
+0.1 (+2.71%)
After Hours:
11/14/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ABCL Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Chartmill
AbCellera Biologics Inc (NASDAQ:ABCL) Reports Mixed Q3 2025 Results with Revenue Beat and Wider Loss
5 days ago - By: AbCellera Biologics Inc.
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
8 days ago - By: Benzinga
- Mentions:
SG
SMR
WYNN
DBX
...
AI Stocks Extend Selloff, Nasdaq 100 Eyes Worst Week Since April: What's Moving Markets Friday?
9 days ago - By: Zacks Investment Research
- Mentions:
CLSD
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates
9 days ago - By: AbCellera Biologics Inc.
AbCellera Reports Q3 2025 Business Results
10 days ago - By: Benzinga
- Mentions:
STVN
PODD
AMRK
SOLV
...
Earnings Scheduled For November 6, 2025
a month ago - By: AbCellera Biologics Inc.
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
2 months ago - By: Zacks Investment Research
- Mentions:
AZN
Is ABCELLERA BIOLG (ABCL) Stock Outpacing Its Medical Peers This Year?
2 months ago - By: AbCellera Biologics Inc.
AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025
2 months ago - By: Zacks Investment Research
AbCellera Biologics Inc. (ABCL) is a Great Momentum Stock: Should You Buy?
2 months ago - By: AbCellera Biologics Inc.
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer
3 months ago - By: AbCellera Biologics Inc.
AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575
3 months ago - By: AbCellera Biologics Inc.
AbCellera to Participate at Upcoming Investor Conferences in September
3 months ago - By: The Motley Fool
AbCellera Biologics (ABCL) Q2 2025 Earnings Call Transcript
3 months ago - By: Zacks Investment Research
- Mentions:
XAIR
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Beats Revenue Estimates
3 months ago - By: AbCellera Biologics Inc.
AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms
3 months ago - By: Zacks Investment Research
- Mentions:
MYGN
Myriad Genetics (MYGN) Q2 Earnings and Revenues Surpass Estimates
4 months ago - By: Yahoo Finance
- Mentions:
VZ
PLTR
AbCellera Biologics Inc. (ABCL): A Bull Case Theory
4 months ago - By: Yahoo Finance
Leerink Partners Affirms Outperform Rating on AbCellera Biologics (ABCL) Following Pivot
4 months ago - By: AbCellera Biologics Inc.
AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025
4 months ago - By: Yahoo Finance
Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating
5 months ago - By: Yahoo Finance
- Mentions:
BRKR
AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology
5 months ago - By: Yahoo Finance
- Mentions:
VZ
AAPL
GOOG
AbCellera Biologics Inc. (ABCL): A Bull Case Theory
6 months ago - By: Yahoo Finance
- Mentions:
O
FLS
GTLS
KIM
...
3 Reasons to Buy Realty Income Stock Like There's No Tomorrow
6 months ago - By: The Motley Fool
Why AbCellera Biologics Stock Raced Nearly 6% Higher Today
6 months ago - By: Yahoo Finance
- Mentions:
APLS
COMP
REGN
Why AbCellera Biologics Stock Raced Nearly 6% Higher Today
6 months ago - By: AbCellera Biologics Inc.
AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575
6 months ago - By: Yahoo Finance
- Mentions:
VZ
UNH
OHI
CSCO
...
Omega Healthcare Investors, Inc. (OHI): A Bull Case Theory
6 months ago - By: Yahoo Finance
- Mentions:
CAPR
CSCO
LRMR
MTCH
...
Capricor Therapeutics, Inc.’s (CAPR): Analysts See 489% Upside Potential
Please enable JavaScript to continue using this application.